문의 support@wisest.co.kr
글로벌 뉴스
글로벌 주요 증시에 상장된 종목 뉴스를 실시간 수집하고 핵심 내용을 인공지능으로 요약 및 번역합니다.
제목을 터치하면 요약된 뉴스 기사와 함께 AI분석(주가 영향 분석)을 볼 수 있습니다.
번역중... Moderna director Noubar Afeyan sells over $1.6m in company stock
2024-04-12T23:19:32.000Z | investing.com
In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ: ), sold a significant amount of company stock, totaling over $1.6 million.
Afeyan's stock sales were spread across four different transactions with varying numbers of shares.
The prices reported are weighted averages, and the specific number of shares sold at each price within the range is available upon request.
After these transactions, Afeyan still holds a substantial number of shares in Moderna.
This P/E ratio underscores the company's recent financial performance, where it has not been profitable over the past year.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ: ), sold a significant amount of company stock, totaling over $1.6 million.
Afeyan's stock sales were spread across four different transactions with varying numbers of shares.
The prices reported are weighted averages, and the specific number of shares sold at each price within the range is available upon request.
After these transactions, Afeyan still holds a substantial number of shares in Moderna.
This P/E ratio underscores the company's recent financial performance, where it has not been profitable over the past year.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
2024-04-12T15:29:14.000Z | finance.yahoo.com
Bill Gates warned about the risk of pandemics well before COVID-19. In 2018, he predicted that "there is a significant probability of a large and lethal, modern-day pandemic occurring in our lifetimes" because of "the continual emergence of new pathogens, the increasing risk of a bioterror attack and how connected our world is through air travel." The same year, Gates announced a $12 million initiative to "accelerate the development of a universal flu vaccine." Don't Miss: Invest alongside exec’
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Bill Gates warned about the risk of pandemics well before COVID-19. In 2018, he predicted that "there is a significant probability of a large and lethal, modern-day pandemic occurring in our lifetimes" because of "the continual emergence of new pathogens, the increasing risk of a bioterror attack and how connected our world is through air travel." The same year, Gates announced a $12 million initiative to "accelerate the development of a universal flu vaccine." Don't Miss: Invest alongside exec’
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... What about the company Vertexdidn’tbuy?
2024-04-12T13:40:17.000Z | statnews.com
Damian here with what is my final edition of The Readout on my last day at STAT.
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
The halted project is another example of how things haven’t quite turned out as Moderna hoped in the years since its early-pandemic peak.
Vertex Pharmaceuticals’ decision to pay $4.9 billion for Alpine Immune Sciences cast a spotlight on the severe kidney disease IgA nephropathy — and, by extension, a company called Vera Therapeutics.
Novartis and Otsuka have competing medicines in development, but Vera is the only other independent biotech firm in the space.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Damian here with what is my final edition of The Readout on my last day at STAT.
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
The halted project is another example of how things haven’t quite turned out as Moderna hoped in the years since its early-pandemic peak.
Vertex Pharmaceuticals’ decision to pay $4.9 billion for Alpine Immune Sciences cast a spotlight on the severe kidney disease IgA nephropathy — and, by extension, a company called Vera Therapeutics.
Novartis and Otsuka have competing medicines in development, but Vera is the only other independent biotech firm in the space.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
2024-04-12T13:16:34.000Z | benzinga.com
The same year, Gates announced a $12 million initiative to "accelerate the development of a universal flu vaccine."
Don't Miss:Now, after a Texas man recently became infected with bird flu after close contact with an infected cow, scientists are concerned about the potential of a pandemic worse than COVID.
However, in light of the increasing number of cattle herds in America contracting the bird flu virus, Shah stresses the CDC is prepared for what may be ahead, saying, "Make no mistake, the CDC is activated as a result of these findings."
Humanity can only hope bird flu doesn't begin to spread easily via person-to-person transmission.
From 2003 to 2016, the virus has killed over 50% of people infected, while the current bird flu outbreak has already hit at least 82 million birds across 48 states.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... The same year, Gates announced a $12 million initiative to "accelerate the development of a universal flu vaccine."
Don't Miss:Now, after a Texas man recently became infected with bird flu after close contact with an infected cow, scientists are concerned about the potential of a pandemic worse than COVID.
However, in light of the increasing number of cattle herds in America contracting the bird flu virus, Shah stresses the CDC is prepared for what may be ahead, saying, "Make no mistake, the CDC is activated as a result of these findings."
Humanity can only hope bird flu doesn't begin to spread easily via person-to-person transmission.
From 2003 to 2016, the virus has killed over 50% of people infected, while the current bird flu outbreak has already hit at least 82 million birds across 48 states.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... $1000 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
2024-04-11T21:37:36.000Z | benzinga.com
Loading... Loading...Moderna MRNA has outperformed the market over the past 5 years by 22.81% on an annualized basis producing an average annual return of 35.1%.
Currently, Moderna has a market capitalization of $40.98 billion.
Buying $1000 In MRNA: If an investor had bought $1000 of MRNA stock 5 years ago, it would be worth $4,141.25 today based on a price of $107.02 for MRNA at the time of writing.
Moderna's Performance Over Last 5 YearsFinally -- what's the point of all this?
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Loading... Loading...Moderna MRNA has outperformed the market over the past 5 years by 22.81% on an annualized basis producing an average annual return of 35.1%.
Currently, Moderna has a market capitalization of $40.98 billion.
Buying $1000 In MRNA: If an investor had bought $1000 of MRNA stock 5 years ago, it would be worth $4,141.25 today based on a price of $107.02 for MRNA at the time of writing.
Moderna's Performance Over Last 5 YearsFinally -- what's the point of all this?
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
2024-04-11T16:24:36.000Z | cnbc.com
Moderna on Thursday said it has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines.
Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint.
It also had plans to start filling doses of its Covid vaccine in the continent as early as 2023.
But the company has since determined that demand in Africa "is insufficient to support the viability of the factory planned in Kenya," Moderna said in a statement on Thursday.
"This approach will allow Moderna to better align its infrastructure investments with the evolving healthcare needs and vaccine demand in Africa."
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Moderna on Thursday said it has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines.
Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint.
It also had plans to start filling doses of its Covid vaccine in the continent as early as 2023.
But the company has since determined that demand in Africa "is insufficient to support the viability of the factory planned in Kenya," Moderna said in a statement on Thursday.
"This approach will allow Moderna to better align its infrastructure investments with the evolving healthcare needs and vaccine demand in Africa."
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
2024-04-11T10:49:21.000Z | benzinga.com
Unlike other therapies that are uniformly designed to treat all patients, the INT aims to bring individualized treatment to cancer patients.
Moderna, Inc. Price Moderna, Inc. price | Moderna, Inc. QuoteLoading... Loading...Zacks Rank & Key PicksModerna currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the overall healthcare sector include ADMA Biologics ADMA and ANI Pharmaceuticals ANIP, each sporting a Zacks Rank #1 (Strong Buy).
In the past 60 days, estimates for ADMA Biologics' 2024 earnings per share have risen from 22 cents to 30 cents.
Earnings of ADMA Biologics beat estimates in three of the last four quarters while meeting the same on one occasion.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Unlike other therapies that are uniformly designed to treat all patients, the INT aims to bring individualized treatment to cancer patients.
Moderna, Inc. Price Moderna, Inc. price | Moderna, Inc. QuoteLoading... Loading...Zacks Rank & Key PicksModerna currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the overall healthcare sector include ADMA Biologics ADMA and ANI Pharmaceuticals ANIP, each sporting a Zacks Rank #1 (Strong Buy).
In the past 60 days, estimates for ADMA Biologics' 2024 earnings per share have risen from 22 cents to 30 cents.
Earnings of ADMA Biologics beat estimates in three of the last four quarters while meeting the same on one occasion.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02%
2024-04-09T20:41:37.000Z | investing.com
Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the , and sectors led shares higher while losses in the , and sectors led shares lower.
At the close in NYSE, the fell 0.02%, while the index climbed 0.14%, and the index gained 0.32%.
The best performers of the session on the were Cisco Systems Inc (NASDAQ: ), which rose 3.67% or 1.77 points to trade at 50.01 at the close.
Meanwhile, Nike Inc (NYSE: ) added 1.11% or 1.00 points to end at 91.00 and Intel Corporation (NASDAQ: ) was up 0.92% or 0.35 points to 38.33 in late trade.
The worst performers of the session were The Travelers Companies Inc (NYSE: ), which fell 2.93% or 6.75 points to trade at 223.84 at the close.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the , and sectors led shares higher while losses in the , and sectors led shares lower.
At the close in NYSE, the fell 0.02%, while the index climbed 0.14%, and the index gained 0.32%.
The best performers of the session on the were Cisco Systems Inc (NASDAQ: ), which rose 3.67% or 1.77 points to trade at 50.01 at the close.
Meanwhile, Nike Inc (NYSE: ) added 1.11% or 1.00 points to end at 91.00 and Intel Corporation (NASDAQ: ) was up 0.92% or 0.35 points to 38.33 in late trade.
The worst performers of the session were The Travelers Companies Inc (NYSE: ), which fell 2.93% or 6.75 points to trade at 223.84 at the close.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Moderna CFO sells shares worth over $71k
2024-04-09T20:22:33.000Z | investing.com
Moderna , Inc. (NASDAQ: ) Chief Financial Officer, James M. Mock, has recently engaged in transactions involving the company's stock, according to the latest SEC filings.
The executive sold a total of 705 shares of Moderna common stock at an average price of $101.9281, netting a total of $71,859.
In addition to the sale, Mock also acquired 1,453 shares of Moderna common stock on April 5th through the conversion of RSUs, which convert on a one-for-one basis.
Following these transactions, CFO James M. Mock now directly owns 5,753 shares of Moderna common stock.
InvestingPro InsightsIn light of the recent transactions by Moderna's CFO, James M. Mock, investors may be curious about the company's financial health and market performance.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... Moderna , Inc. (NASDAQ: ) Chief Financial Officer, James M. Mock, has recently engaged in transactions involving the company's stock, according to the latest SEC filings.
The executive sold a total of 705 shares of Moderna common stock at an average price of $101.9281, netting a total of $71,859.
In addition to the sale, Mock also acquired 1,453 shares of Moderna common stock on April 5th through the conversion of RSUs, which convert on a one-for-one basis.
Following these transactions, CFO James M. Mock now directly owns 5,753 shares of Moderna common stock.
InvestingPro InsightsIn light of the recent transactions by Moderna's CFO, James M. Mock, investors may be curious about the company's financial health and market performance.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.
번역중... Southland top 20 high school softball rankings
2024-04-09T19:53:23.000Z | aol.com
April 10, 2024 at 3:59 AMThe top 20 high school softball rankings for The Times by CalHiSports.com.
(2) Murrieta Mesa 18-23.
(NR) Sherman Oaks Notre Dame 15-420.
(19) Marina 14-7-1Sign up for the L.A. Times SoCal high school sports newsletter to get scores, stories and a behind-the-scenes look at what makes prep sports so popular.
This story originally appeared in Los Angeles Times.
AI로 요약한 내용입니다. 본문을 터치하면 번역문이 표시됩니다.
번역중... April 10, 2024 at 3:59 AMThe top 20 high school softball rankings for The Times by CalHiSports.com.
(2) Murrieta Mesa 18-23.
(NR) Sherman Oaks Notre Dame 15-420.
(19) Marina 14-7-1Sign up for the L.A. Times SoCal high school sports newsletter to get scores, stories and a behind-the-scenes look at what makes prep sports so popular.
This story originally appeared in Los Angeles Times.
AI로 번역한 내용입니다. 본문을 터치하면 영어 원문이 표시됩니다.